Significant up-regulation of CBX3 had been found in a variety of cancers, including lung adenocarcinoma (LUAD) and non-small cell lung cancer (nSCLC), tongue squamous cell carcinoma (TSCC), and colorectal cancer [24–27]. This evidence concerns the gene CBX3 and colorectal cancer.